Symbol="MRKR"
AssetType="Common Stock"
Name="Marker Therapeutics Inc"
Description="Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas."
CIK="1094038"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="50 N LAURA STREET, SUITE 2500, JACKSONVILLE, FL, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="56928000"
EBITDA="-22172276"
PERatio="None"
PEGRatio="None"
BookValue="1.809"
DividendPerShare="0"
DividendYield="0"
EPS="-2.88"
RevenuePerShareTTM="1.512"
ProfitMargin="-1.955"
OperatingMarginTTM="-1.972"
ReturnOnAssetsTTM="-0.38"
ReturnOnEquityTTM="-0.968"
RevenueTTM="12783600"
GrossProfitTTM="-17125779"
DilutedEPSTTM="-2.88"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="3.909"
AnalystTargetPrice="40"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.593"
PriceToBookRatio="1.134"
EVToRevenue="3.641"
EVToEBITDA="-0.472"
Beta="1.142"
num_52WeekHigh="9.68"
num_52WeekLow="0.671"
num_50DayMovingAverage="3.723"
num_200DayMovingAverage="2.816"
SharesOutstanding="8798800"
DividendDate="2016-09-16"
ExDividendDate="None"
symbol="MRKR"
open="6.27"
high="6.41"
low="4.77"
price="5.05"
volume="432501.00"
latest_trading_day="2023-07-31"
previous_close="6.47"
change="-1.42"
change_percent="-21.9474%"
aroon_positive_momentum_days="37"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="603590"
Change_recent_avg="0.03"
Delta_recent_avg="0.39"
Variance_recent_avg="0.19"
Change_ratio_recent_avg="0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_negative_thumbnail_id_2="1093"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="634"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0074.jpeg"
image_positive_thumbnail_id_2="621"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0087.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
